内科理论与实践 ›› 2023, Vol. 18 ›› Issue (05): 368-371.doi: 10.16138/j.1673-6087.2023.05.013
木卡大斯·热合曼, 蒋婕, 童建菁(
)
收稿日期:2022-08-10
出版日期:2023-10-30
发布日期:2024-01-25
通讯作者:
童建菁
E-mail:tjj10884@rjh.com.cn
Mukadas Rahman, JIANG Jie, TONG Jianjing()
Received:2022-08-10
Online:2023-10-30
Published:2024-01-25
Contact:
TONG Jianjing
E-mail:tjj10884@rjh.com.cn
中图分类号:
木卡大斯·热合曼, 蒋婕, 童建菁. 咖啡对消化系统恶性肿瘤影响的研究进展[J]. 内科理论与实践, 2023, 18(05): 368-371.
Mukadas Rahman, JIANG Jie, TONG Jianjing. Research progress on the effects of coffee on malignant tumors of digestive system[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(05): 368-371.
| [1] |
Butt MS, Sultan MT. Coffee and its consumption: benefits and risks[J]. Crit Rev Food Sci Nutr, 2011, 51(4): 363-373.
doi: 10.1080/10408390903586412 pmid: 21432699 |
| [2] |
Loftfield E, Freedman ND, Dodd KW, et al. Coffee drinking is widespread in the United States, but usual intake varies by key demographic and lifestyle factors[J]. J Nutr, 2016, 146(9): 1762-1768.
doi: 10.3945/jn.116.233940 pmid: 27489008 |
| [3] | 朱晓, 李建文, 刘飒娜, 等. 我国成年人咖啡饮用状况调查及其影响因素分析[J]. 现代预防医学, 2018. 45(22): 4043-4045. |
| [4] | 文志华, 毕晓菲, 鲁维艳. 中国咖啡消费趋势浅谈[J]. 农产品加工(下半月), 2018(1): 69-70. |
| [5] |
Saeed M, Naveed M, BiBi J, et al. Potential nutraceutical and food additive properties and risks of coffee: a comprehensive overview[J]. Crit Rev Food Sci Nutr, 2019, 59(20): 3293-3319.
doi: 10.1080/10408398.2018.1489368 pmid: 30614268 |
| [6] |
Liu D, Li ZH, Shen D, et al. Association of sugar-sweetened, artificially sweetened, and unsweetened coffee consumption with all-cause and cause-specific mortality[J]. Ann Intern Med, 2022, 175(7): 909-917.
doi: 10.7326/M21-2977 URL |
| [7] |
Zhou A, Hyppönen E. Long-term coffee consumption, caffeine metabolism genetics, and risk of cardiovascular disease: a prospective analysis of up to 347,077 individuals and 8368 cases[J]. Am J Clin Nutr, 2019, 109(3):509-516.
doi: 10.1093/ajcn/nqy297 pmid: 30838377 |
| [8] |
Bae JM. Coffee consumption and risk of type 2 diabetes mellitus in Asians: a meta-epidemiological study of population-based cohort studies[J]. World J Diabetes, 2021, 12(6): 908-915.
doi: 10.4239/wjd.v12.i6.908 URL |
| [9] |
Gardener SL, Rainey-Smith SR, Villemagne VL, et al. Higher coffee consumption is associated with slower cognitive decline and less cerebral Aβ-amyloid accumulation over 126 months[J]. Front Aging Neurosci, 2021, 13:744872.
doi: 10.3389/fnagi.2021.744872 URL |
| [10] |
Arnold M, Abnet CC, Neale RE, et al. Global burden of 5 major types of gastrointestinal cancer[J]. Gastroenterology, 2020, 159(1): 335-349.
doi: S0016-5085(20)30452-2 pmid: 32247694 |
| [11] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
doi: 10.3322/caac.v68.6 URL |
| [12] |
Yu X, Bao Z, Zou J, et al. Coffee consumption and risk of cancers: a meta-analysis of cohort studies[J]. BMC cancer, 2011, 11: 96.
doi: 10.1186/1471-2407-11-96 pmid: 21406107 |
| [13] |
He T, Guo X, Li X, et al. Association between coffee intake and the risk of oral cavity cancer: a meta-analysis of observational studies[J]. Eur J Cancer Prev, 2020, 29(1):80-88.
doi: 10.1097/CEJ.0000000000000515 pmid: 31021885 |
| [14] |
Hildebrand JS, Patel AV, McCullough ML, et al. Coffee, tea, and fatal oral/pharyngeal cancer in a large prospective US cohort[J]. Am J Epidemiol, 2013, 177(1): 50-58.
doi: 10.1093/aje/kws222 pmid: 23230042 |
| [15] |
Zhang J, Zhou B, Hao C. Coffee consumption and risk of esophageal cancer incidence: a meta-analysis of epidemiologic studies[J]. Medicine, 2018. 97(17): e0514.
doi: 10.1097/MD.0000000000010514 URL |
| [16] |
Loomis D, Guyton KZ, Grosse Y, et al. Carcinogenicity of drinking coffee, mate, and very hot beverages[J]. Lancet Oncol, 2016, 17(7): 877-878.
doi: S1470-2045(16)30239-X pmid: 27318851 |
| [17] |
Brown F, Diller KR. Calculating the optimum temperature for serving hot beverages[J]. Burns, 2008, 34(5): 648-654.
doi: 10.1016/j.burns.2007.09.012 pmid: 18226454 |
| [18] |
Song H, Shen X, Chu Q, et al. Coffee consumption is not associated with the risk of gastric cancer[J]. Nutr Res, 2022, 102: 35-44.
doi: 10.1016/j.nutres.2022.03.002 URL |
| [19] |
Li L, Gan Y, Wu C, et al. Coffee consumption and the risk of gastric cancer: a meta-analysis of prospective cohort studies[J]. Nutr Cancer, 2016, 68(1): 40-47.
doi: 10.1080/01635581.2016.1115093 URL |
| [20] | Ainslie-Waldman CE, Koh WP, Jin A, et al. Coffee intake and gastric cancer risk[J]. Cancer Epidemiol Bio-markers Prev, 2014, 23(4): 638-647. |
| [21] |
Martimianaki G, Bertuccio P, Alicandro G, et al. Coffee consumption and gastric cancer[J]. Eur J Cancer Prev, 2022, 31(2): 117-127.
doi: 10.1097/CEJ.0000000000000680 URL |
| [22] |
Bae JM. Coffee consumption and colon cancer risk[J]. Asian Pac J Cancer Prev, 2020, 21(5): 1177-1179.
doi: 10.31557/APJCP.2020.21.5.1177 URL |
| [23] |
Mackintosh C, Yuan C, Ou FS, et al. Association of coffee intake with survival in patients with advanced or metastatic colorectal cancer[J]. JAMA Oncol, 2020, 6(11): 1713-1721.
doi: 10.1001/jamaoncol.2020.3938 URL |
| [24] |
Um CY, McCullough ML, Guinter MA, et al. Coffee consumption and risk of colorectal cancer in the cancer prevention study-Ⅱ nutrition cohort[J]. Cancer Epidemiol, 2020, 67: 101730.
doi: 10.1016/j.canep.2020.101730 URL |
| [25] |
Li TD, Yang HW, Wang P, et al. Coffee consumption and risk of pancreatic cancer: a systematic review and dose-response meta-analysis[J]. Int J Food Sci Nutr, 2019, 70(5): 519-529.
doi: 10.1080/09637486.2018.1551337 URL |
| [26] |
Zhou CD, Kuan AS, Reeves GK, et al. Coffee and pancreatic cancer risk among never-smokers in the UK prospective million women study[J]. Int J Cancer, 2019, 145(6): 1484-1492.
doi: 10.1002/ijc.31994 pmid: 30426487 |
| [27] |
Gallus S, Bertuzzi M, Tavani A, et al. Does coffee protect against hepatocellular carcinoma?[J]. Br J Cancer, 2002, 87(9): 956-959.
doi: 10.1038/sj.bjc.6600582 |
| [28] |
Tamura T, Wada K, Konishi K, et al. Coffee, green tea, and caffeine intake and liver cancer risk[J]. Nutr Cancer, 2018, 70(8): 1210-1216.
doi: 10.1080/01635581.2018.1512638 URL |
| [29] |
Loftfield E, Rothwell JA, Sinha R, et al. Prospective investigation of serum metabolites, coffee drinking, liver cancer incidence, and liver disease mortality[J]. J Natl Cancer Inst, 2020, 112(3): 286-294.
doi: 10.1093/jnci/djz122 pmid: 31168595 |
| [30] |
Tamura T, Hishida A, Wakai K. Coffee consumption and liver cancer risk in Japan: a meta-analysis of six prospective cohort studies[J]. Nagoya J Med Sci, 2019, 81(1): 143-150.
doi: 10.18999/nagjms.81.1.143 pmid: 30962663 |
| [31] |
Kennedy OJ, Roderick P, Buchanan R, et al. Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma[J]. BMJ Open, 2017, 7(5): e013739.
doi: 10.1136/bmjopen-2016-013739 URL |
| [32] | Bhurwal A, Rattan P, Yoshitake S, et al. Inverse association of coffee with liver cancer development[J]. J Gastrointestin Liver Dis, 2020, 29(3): 421-428. |
| [33] |
Larsson SC, Giovannucci EL, Wolk A. Coffee consumption and risk of gallbladder cancer in a prospective study[J]. J Natl Cancer Inst, 2017, 109(3): 1-3.
doi: 10.1093/jnci/djw237 pmid: 28376203 |
| [34] | Nigra AD, Teodoro AJ, Gil GA. A decade of research on coffee as an anticarcinogenic beverage[J]. Oxid Med Cell Longev, 2021, 2021: 4420479. |
| [35] |
Bessler H, Salman H, Bergman M, et al. Caffeine alters cytokine secretion by PBMC induced by colon cancer cells[J]. Cancer Invest, 2012, 30(2): 87-91.
doi: 10.3109/07357907.2011.636113 pmid: 22149008 |
| [36] |
Merighi S, Benini A, Mirandola P, et al. Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells[J]. Mol Pharmacol, 2007, 72(2): 395-406.
doi: 10.1124/mol.106.032920 pmid: 17488804 |
| [37] |
Kumamoto-Yonezawa Y, Sasaki R, Ota Y, et al. Cell cycle arrest triggered by conjugated eicosapentaenoic acid occurs through several mechanisms including G1 checkpoint activation by induced RPA and ATR expression[J]. Biochim Biophys Acta, 2009, 1790(5): 339-346.
doi: 10.1016/j.bbagen.2009.02.004 pmid: 19364474 |
| [38] |
Lu GY, Huang SM, Liu ST, et al. Caffeine induces tumor cytotoxicity via the regulation of alternative splicing in subsets of cancer-associated genes[J]. Int J Biochem Cell Biol, 2014, 47: 83-92.
doi: 10.1016/j.biocel.2013.12.004 URL |
| [39] |
Jiemjit A, Fandy TE, Carraway H, et al. p21(WAF1/CIP1) induction by 5-azacytosine nucleosides requires DNA damage[J]. Oncogene, 2008, 27(25): 3615-3623.
doi: 10.1038/sj.onc.1211018 pmid: 18223691 |
| [40] |
Ciaramelli C, Palmioli A, Airoldi C. Coffee variety, origin and extraction procedure: implications for coffee beneficial effects on human health[J]. Food Chem, 2019, 278: 47-55.
doi: S0308-8146(18)32001-6 pmid: 30583399 |
| [41] |
Hou N, Liu N, Han J, et al. Chlorogenic acid induces reactive oxygen species generation and inhibits the viability of human colon cancer cells[J]. Anticancer Drugs, 2017, 28(1): 59-65.
doi: 10.1097/CAD.0000000000000430 pmid: 27603595 |
| [42] |
Rakshit S, Mandal L, Pal BC, et al. Involvement of ROS in chlorogenic acid-induced apoptosis of Bcr-Abl+ CML cells[J]. Biochem Pharmacol, 2010, 80(11): 1662-1675.
doi: 10.1016/j.bcp.2010.08.013 URL |
| [43] |
Yan Y, Li J, Han J, et al. Chlorogenic acid enhances the effects of 5-fluorouracil in human hepatocellular carcinoma cells through the inhibition of extracellular signal-regulated kinases[J]. Anticancer Drugs, 2015, 26(5): 540-546.
doi: 10.1097/CAD.0000000000000218 pmid: 25714249 |
| [44] |
Choi DW, Lim MS, Lee JW, et al. The cytotoxicity of kahweol in HT-29 human colorectal cancer cells is mediated by apoptosis and suppression of heat shock protein 70 expression[J]. Biomol Ther (Seoul), 2015, 23(2): 128-133.
doi: 10.4062/biomolther.2014.133 URL |
| [45] |
Sanlier N, Atik A, Atik I. Consumption of green coffee and the risk of chronic diseases[J]. Crit Rev Food Sci Nutr, 2019, 59(16): 2573-2585.
doi: 10.1080/10408398.2018.1461061 pmid: 29624417 |
| [1] | 徐丽辰, 李贵森. 局灶节段性肾小球硬化发病机制及治疗进展[J]. 内科理论与实践, 2023, 18(05): 363-367. |
| [2] | 顾燕云, 周薇薇, 王卫庆, 宁光. 原发性色素沉着结节性肾上腺皮质病[J]. 内科理论与实践, 2023, 18(04): 230-233. |
| [3] | 张翠, 王卫庆. 异位促肾上腺皮质激素综合征[J]. 内科理论与实践, 2023, 18(04): 242-246. |
| [4] | 张婕, 毕宇芳. 神经内分泌肿瘤发病的代谢危险因素[J]. 内科理论与实践, 2023, 18(04): 251-255. |
| [5] | 张婕, 陆洁莉. 非胰岛细胞肿瘤所致的低血糖临床诊治进展[J]. 内科理论与实践, 2023, 18(04): 256-260. |
| [6] | 刘益飞. DNA甲基化检测助力肿瘤早期筛查和诊断[J]. 诊断学理论与实践, 2023, 22(04): 393-401. |
| [7] | 吴春晓, 顾凯, 庞怡, 王春芳, 施亮, 向詠梅, 龚杨明, 窦剑明, 施燕, 付晨. 2002—2016年上海市小肠癌发病、死亡和生存分析[J]. 外科理论与实践, 2023, 28(03): 240-248. |
| [8] | 史玉玲, 陈文娟. 银屑病共病的现状及诊治[J]. 诊断学理论与实践, 2023, 22(03): 221-229. |
| [9] | 王泽洲, 郑莹. 1990年至2020年间全球及我国肺癌的发病流行趋势及防控措施[J]. 诊断学理论与实践, 2023, 22(01): 1-7. |
| [10] | 梁晨, 于佳佳, 唐神结. 世界卫生组织《全球结核病报告2022》解读[J]. 诊断学理论与实践, 2023, 22(01): 21-30. |
| [11] | 罗茜, 施咏梅, 陈科, 姜烁, 吴雨薇. 应用改良版病人主观综合评估量表评估胃肠癌症病人的研究[J]. 外科理论与实践, 2022, 27(06): 545-550. |
| [12] | 缪雅, 刘丽丽, 侯田志超, 严青华, 庞怡, 吴春晓, 程旻娜, 施燕, 黎衍云, 田景琰. 上海糖尿病前期人群恶性肿瘤发病风险分析[J]. 内科理论与实践, 2022, 17(06): 435-440. |
| [13] | 郑毓真, 郑彦俊, 周易, 祁星, 陈薇薇, 史雯, 周伟君, 杨之涛, 陈影, 毛恩强, 陈尔真. 综合性医院674例脓毒症住院患者的回顾性临床分析[J]. 内科理论与实践, 2022, 17(04): 278-282. |
| [14] | 鲍萍萍, 吴春晓, 顾凯, 庞怡, 王春芳, 施亮, 向詠梅, 龚杨明, 窦剑明, 吴梦吟, 付晨, 施燕. 上海市2016年胃癌发病特征及2002年至2016年胃癌发病趋势分析[J]. 诊断学理论与实践, 2022, 21(04): 462-469. |
| [15] | 何新, 陈慧, 冯炜炜. 机器学习算法在辅助超声诊断附件肿块良恶性中的应用研究进展[J]. 诊断学理论与实践, 2022, 21(04): 541-546. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||
